Table 1:
In-Care Viral Load (ICVL) among DC Cohort participants with an incident STI (one or more) in 2012–2016, stratified by baseline demographic characteristics. ICVL shown in [COPIES/ML].
In-Care Viral Load (SD) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2012(n=123) | 2013(n=236) | 2014(n=247) | 2015(n=299) | 2016(n=296) | P | ||||||
Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | ||
Overall: | 108 (1,54173) | 123 | 54 (1,61638) | 236 | 32 (1,55823) | 247 | 24(1,33480) | 299 | 19 (1,60743) | 296 | |
Age at enrollment: | |||||||||||
13–18 | 3064 (3064,3064) | 1 | 686 (1,111848) | 9 | 663 (10.5,16731) | 4 | 3018 (5.75,26259) | 5 | 56 (1,11645) | 4 | 0.3579 |
18–35 | 211 (1,103972) | 51 | 101 (1,78134) | 111 | 43 (1,63896) | 121 | 51 (1,44111) | 128 | 35 (1,81491) | 116 | <0.0001 |
35–54 | 64 (1,30347) | 68 | 30 (1,25938) | 99 | 27 (1,22670) | 108 | 12 (1,12759) | 135 | 15 (1,40866) | 145 | <0.0001 |
55+ | 59 (1,684.2) | 3 | 9 (1,71814) | 17 | 3 (1,51513) | 14 | 8 (1,5167.5) | 31 | 6 (1,12615) | 31 | 0.0005 |
Gender: | |||||||||||
Cisgender M | 103 (1,80948) | 114 | 50 (1,61638) | 202 | 24 (1,55823) | 204 | 16 (1,14740) | 258 | 15 (1,41419) | 264 | 0.0003 |
Cisgender F | 155 (1,4357.7) | 7 | 77 (1,46745) | 22 | 89 (1,57650) | 28 | 583 (1,73542) | 25 | 370 (1,292357) | 19 | 0.0656 |
Transgender F | 524 (94.2,2910) | 2 | 113 (1,23447) | 12 | 176 (1,20664) | 15 | 94 (1,40470) | 16 | 53 (1,257574) | 13 | 0.0036 |
Transgender M | NA (NA) | 0 | NA(NA) | 0 | NA(NA) | 0 | NA(NA) | 0 | NA(NA) | 0 | NA |
Race/Ethnicity: | |||||||||||
Non-Hisp. Black | 226 (1,80948) | 81 | 77 (1,61638) | 166 | 53 (1,63716) | 177 | 39 (1,40105) | 218 | 29 (1,60743) | 204 | <0.0001 |
Non-Hisp. White | 41 (1,19524) | 33 | 29 (1,71814) | 51 | 9 (1,12469) | 45 | 4 (1,6560) | 52 | 6 (1,105820) | 55 | <0.0001 |
Hispanic | 6 (1,88) | 8 | 11 (1,15187) | 16 | 7 (1,1372.9) | 20 | 12 (1,29269) | 27 | 13 (1,32325) | 36 | 0.0325 |
Other | 1 (1,1)) | 1 | 67 (20,591.33) | 3 | 21 (1,2029.5) | 5 | 417 (168.67,1030) | 2 | 1 (1,1) | 1 | 0.2960 |
Unknown | NA (NA) | 0 | NA(NA) | 0 | NA(NA) | 0 | NA(NA) | 0 | NA (NA) | 0 | NA |
Insurance: | |||||||||||
Private | 60 (1,103972) | 36 | 19 (1,32534) | 64 | 12 (1,55867) | 73 | 7 (1,16540) | 92 | 9 (1,79240) | 77 | <0.0001 |
Public | 119 (1,54173) | 72 | 71 (1,46745) | 124 | 57 (1,57650) | 145 | 46 (1,39045) | 176 | 21 (1,40866) | 193 | <0.0001 |
Other/Unknown | 282 (1,1040000) | 15 | 113 (1,129220) | 48 | 18 (1,16175) | 29 | 20 (1,6484.2) | 31 | 88 (1,124930) | 26 | 0.0021 |
Housing: | |||||||||||
Permanent | 114 (1,82160) | 85 | 44 (1,50410) | 164 | 27 (1,45630) | 181 | 20 (1,26259) | 219 | 18 (1,60743) | 224 | <0.0001 |
Temp./Homeless | 157 (1,17577) | 17 | 75 (1,29633) | 24 | 52 (1,100939) | 31 | 40 (1,44111) | 42 | 9 (1,56060) | 35 | <0.0001 |
Other/Unknown | 65 (1,30584) | 21 | 95 (1,67677) | 48 | 47 (1,57650) | 35 | 36 (1,40105) | 38 | 58 (1,257574) | 37 | 0.1822 |
Risk for HIV: | |||||||||||
MSM | 114 (12.8,3064) | 112 | 52 (1,61638) | 194 | 28 (1,55823) | 201 | 17 (1,14740) | 248 | 16 (1,60743) | 247 | <0.0001 |
HRH | 32 (1,4357.7) | 6 | 10 (1,3477.5) | 16 | 63 (1,54167) | 25 | 60 (1,88145) | 27 | 77 (1,275735) | 28 | 0.0004 |
IDU | NA (NA) | 0 | 66 (1,2878.7) | 8 | 71 (1,2200.6) | 4 | 200 (1,9946.3) | 6 | 5 (1,24610) | 6 | 0.9376 |
Other/Unknown | 115 (1,80948) | 5 | 333 (1,111848) | 18 | 41 (1,65939) | 17 | 263 (1,53436) | 18 | 48 (1,40866) | 15 | 0.6190 |
STI Diagnosis: | |||||||||||
1 | 102 (1,80948) | 107 | 54 (1,61638) | 199 | 25 (1,41810) | 210 | 23 (1,40105) | 235 | 23 (1,60743) | 231 | <0.0001 |
2+ | 163 (1,19524) | 16 | 60 (1,71814) | 37 | 129 (1,80603) | 37 | 27 (1,25496) | 64 | 11(1,41419) | 65 | 0.0163 |
CI, confidence interval; NA, not applicable (i.e., zero cases; insufficient data for calculation); MSM, men who have sex with men; HRH, high risk heterosexual; IDU, injection drug use. P-values are based on a linear test of trend across the five years.